These data suggest that the MPRG-derived riskscore correlated with increased immunosuppressive M2 macrophage dominance and reduced cytotoxic CD4 + T cell presence, potentially driving a more immunosuppressive tumor microenvironment. The gene discussed is CD4; the disease is neoplasm.